Hanmi to develop a new therapeutic kit for glaucoma.

Published: 2005-11-15 06:56:00

Updated: 2005-11-15 06:56:00

Hanmi announced to introduce a new therapeutic kit for "Lataro eye drop"(0.005% of latanoprost), an eye drop for the treatment of various types of glaucoma by using 5 different patent applied technologies including a special nozzle designed for the patient to administer the solution in a fixed do...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK